EW Filing
4Filing Date: Jul 27, 2026

Edwards Lifesciences Corp (EW) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001225208-26-006743open_in_new
Total Value$245.1K
Trades4
Insiders1

Transaction Details

Zovighian Bernard J
CEO, Director·Indirect · By Trust
Gift · Acquire
Common Stock
Shares+319.65
Price$0.00
Total Value$0
Shares Owned After11.84K
Transaction DateJul 27, 2026
Zovighian Bernard J
CEO, Director·Direct
Gift · Dispose
Common Stock
Shares-319.65
Price$0.00
Total Value$0
Shares Owned After98.84K
Transaction DateJul 27, 2026
Zovighian Bernard J
CEO, Director·Indirect · By Trust
Sell · Dispose
Common Stock
Shares-2.92K
Price$83.93
Total Value$245.1K
Shares Owned After8.92K
Transaction DateJul 27, 2026
Zovighian Bernard J
CEO, Director·Indirect · 401(k)
Common Stock
Shares0
Price-
Total Value$0
Shares Owned After3.73K

Post-Transaction Holdings

Zovighian Bernard J
SecuritySharesChange
Common Stock110.68K-2.92K (-2.57%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-27 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Edwards Lifesciences Corp (EW) CIK: 0001099800 --- Reporting Owner --- Name: Zovighian Bernard J CIK: 0001665141 Role: Director, Officer (CEO) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-07-27 | Code: G (Gift) Shares: -319.6499 | Price: $0.00 Shares Owned After: 98,845 | Ownership: D (Direct) [Transaction #2] Security: Common Stock Date: 2026-07-27 | Code: G (Gift) Shares: +319.6499 | Price: $0.00 Shares Owned After: 11,836.201 | Ownership: I (Indirect) | Nature: By Trust [Transaction #3] Security: Common Stock Date: 2026-07-27 | Code: S (Open market sale) Shares: -2,920.5511 | Price: $83.93 Total Value: $245,134.12 Shares Owned After: 8,915.6499 | Ownership: I (Indirect) | Nature: By Trust --- Holdings --- [Holding #1] Security: Common Stock Ownership: I (Indirect) --- Signature --- /s/ Linda J. Park, Attorney-in-Fact (2026-07-27)

keid AI analysis is for reference only and does not constitute investment advice.